Showing 1 - 8 results of 8 for search '"Republicanism"', query time: 0.07s Refine Results
  1. 1
    Experience of targeted therapy for ALK positive non-small cell lung cancer – a clinical case

    Experience of targeted therapy for ALK positive non-small cell lung cancer – a clinical case by A. V. Sultanbaev, Sh. I. Musin, K. V. Menshikov, A. F. Nasretdinov, B. A. Ibragimov, A. G. Nigmatullin, R. T. Ayupov, A. A. Izmailov, N. I. Sultanbaeva

    Published 2020-12-01
    Get full text
    Article
  2. 2
    Optimal solutions in the third line therapy for refractory metastatic colorectal cancer. CORRECTness and CONCURency

    Optimal solutions in the third line therapy for refractory metastatic colorectal cancer. CORRECTness and CONCURency by R. T. Ayupov, A. A. Izmailov, K. V. Menshikov, A. V. Sultanbaev, A. F. Nasretdinov, R. R. Rakhimov, Sh. I. Musin, N. I. Sultanbaeva

    Published 2021-12-01
    Get full text
    Article
  3. 3
    Clinical case of the treatment of metastatic luminal breast cancer

    Clinical case of the treatment of metastatic luminal breast cancer by A. F. Nasretdinov, A. V. Sultanbaev, K. V. Menshikov, Sh. I. Musin, N. I. Sultanbaeva, A. A. Izmailov, R. T. Ayupov

    Published 2021-12-01
    Get full text
    Article
  4. 4
    Experience in treating BRCA-associated breast cancer. The BRCA-history of a family

    Experience in treating BRCA-associated breast cancer. The BRCA-history of a family by A. V. Sultanbaev, K. V. Menshikov, A. F. Nasretdinov, A. A. Izmailov, S. I. Musin, I. A. Menshikova, A. V. Chashchin, N. I. Sultanbaeva

    Published 2021-08-01
    Get full text
    Article
  5. 5
    Inhibitors of cyclin-dependent kinases 4/6 for breast cancer patients with different somatic mutations of the PIK3CA gene

    Inhibitors of cyclin-dependent kinases 4/6 for breast cancer patients with different somatic mutations of the PIK3CA gene by A. F. Nasretdinov, N. I. Sultanbaeva, Sh. I. Musin, O. N. Lipatov, A. A. Izmailov, R. T. Ayupov, K. V. Menshikov, A. V. Pushkarev, A. V. Sultanbaev

    Published 2020-12-01
    Get full text
    Article
  6. 6
    Metastatic renal cell carcinoma, the possibility of targeted therapy. Case.

    Metastatic renal cell carcinoma, the possibility of targeted therapy. Case. by K. V. Menshikov, A. A. Izmailov, A. V. Sultanbaev, Sh. I. Musin, V. S. Chalov, I. A. Menshikova, N. I. Sultanbaeva, D. O. Lipatov

    Published 2021-12-01
    Get full text
    Article
  7. 7
    Efficacy of the 1<sup>st</sup> generation tyrosine kinase inhibitor sunitinib in the treatment of metastatic renal cell carcinoma in alternative dosing regimens

    Efficacy of the 1<sup>st</sup> generation tyrosine kinase inhibitor sunitinib in the treatment of metastatic renal cell carcinoma in alternative dosing regimens by K. V. Menshikov, A. V. Sultanbaev, Sh. I. Musin, A. A. Izmailov, V. S. Chalov, I. A. Menshikova, N. I. Sultanbaeva, E. V. Popova, D. O. Lipatov

    Published 2022-06-01
    Get full text
    Article
  8. 8
    Clinical case of surgical treatment of advanced basal cell carcinoma of the skin on the face

    Clinical case of surgical treatment of advanced basal cell carcinoma of the skin on the face by N. A. Sharafutdinova, Sh. I. Musin, A. V. Sultanbayev, K. V. Menshikov, V. V. Ilyin, B. A. Ibragimov, A. A. Izmailov, I. A. Sharifgaliev, F. D. Zainullin

    Published 2022-12-01
    “…In November of 2021, when the patient first consulted at the Republican Clinical Oncological Dispensary of the ministry of Health of the Bashkortostan Republic, the tumor was 7 × 5 cm. …”
    Get full text
    Article

Search Tools: